Skip to main content

What Steris's Quarter ended Sep 30, 2026 10-Q says: 5 signals

Steris filed its latest 10-Q with the SEC on Nov 5, 2026. It discusses acquisition announced, acquisition completed and international growth.

Public (STE)Medical Equipment Manufacturing10,000+ employeessteris.comLinkedIn

Get Steris' live signals in Claude or ChatGPT, or by API

AskWhat changed at Steris this week? Use Autobound signals for steris.com.
Filed
Nov 5, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
15

Source: Autobound Signal API · 95 signals tracked for Steris · updated

10-Q · latest 10

What Steris's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 5 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 5 signals

    SEC EDGAR

Earlier 10-Q filings

  • 10-Q · Quarter ended Dec 31, 2025Filed · 5 signalsSEC EDGAR

Showing 10 of 15 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Steris earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Agreement to acquire Xodus Medical expands surgical consumablesThe company entered an agreement to acquire Xodus Medical, expanding single-use operating room consumables including patient positioning, patient warming, and handling products. Xodus brings direct OR commercial access, mid-teens revenue growth expectations, and EBIT margins in the low to mid-50s funded via debt.
Revenue grew 9% to $1.6B with 45.3% gross marginSecond quarter as-reported revenue rose 9% to $1.6 billion, with constant currency organic revenue expanding 8% supported by 230 basis points of pricing. Adjusted gross margin reached 45.3%, benefiting from roughly $20 million in tariff refunds, while adjusted EBIT margin expanded 150 basis points to 24.6%.
Life Sciences revenue surged 18% led by capital equipmentLife Sciences constant currency organic revenue expanded 18% in Q2, propelled by a 53% surge in capital equipment shipments, 9% consumables growth, and a $10 million single-customer order. Segment EBIT margins set a record at 44.4%, up 310 basis points, aided by reshoring trends.
Fiscal 2027 diluted EPS guidance raised to $11.35-$11.55Full-year fiscal 2027 adjusted diluted EPS guidance was increased to a range of $11.35 to $11.55 from the prior $11.10 to $11.30 range. Management also raised Life Sciences constant currency organic growth outlook to 9%-10% from 6%-7% previously.
Applied Sterilization Technologies fiscal 2027 growth outlook loweredManagement lowered constant currency organic revenue growth expectations for Applied Sterilization Technologies (AST) to 6% to 7%, down from the prior 7% to 8% range. The revision aligns the full-year forecast with the second quarter exit run-rate following soft procedure volumes.
Second quarter capital expenditures totaled $76.1M across facilitiesSTERIS recorded capital expenditures of $76.1 million for the second quarter alongside $125.6 million in depreciation and amortization. Operational spending prioritized ongoing capacity loadings and facility investments across processing and manufacturing networks.

Signal API · MCP

Track Steris with the Signal API

One POST /v1/companies/enrich call with steris.com returns Steris 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"steris.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Steris 10-Q

When did Steris file its latest 10-Q?
Steris filed its latest 10-Q (Quarter ended Sep 30, 2026) on Nov 5, 2026. The one before it was filed on Aug 7, 2026.
What did Steris disclose in its latest 10-Q?
From the filing dated Nov 5, 2026: STERIS to acquire Xodus Medical for $2.1 billion in cash plus $150 million earnout
What did Steris say on its recent earnings calls?
Q2 FY2027: Agreement to acquire Xodus Medical expands surgical consumables (dated Nov 5, 2026).
Where can I read Steris's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1757898/000162828026070997/ste-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →